CN Patent

CN118076621A — 多羟基化的环戊烷衍生物及使用方法

Assigned to Saint Germain Biotech Inc · Expires 2024-05-24 · 2y expired

What this patent protects

本公开内容提供了式(I)或式(II)的接头化合物，其药学上可接受的盐，以及相关的支架和缀合物。本公开内容还涉及接头化合物、支架和缀合物的用途，例如在递送核酸和/或治疗或预防疾病中的用途。

USPTO Abstract

本公开内容提供了式(I)或式(II)的接头化合物，其药学上可接受的盐，以及相关的支架和缀合物。本公开内容还涉及接头化合物、支架和缀合物的用途，例如在递送核酸和/或治疗或预防疾病中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN118076621A
Jurisdiction
CN
Classification
—
Expires
2024-05-24
Drug substance claim
No
Drug product claim
No
Assignee
Saint Germain Biotech Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.